FdaApplication
ANDA 204620
Identifiers
- fda_app_no: ANDA204620
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2020-06-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLOPATADINE HYDROCHLORIDE | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS;OPHTHALMIC |
1 product